Your browser doesn't support javascript.
loading
Functional mapping of androgen receptor enhancer activity.
Huang, Chia-Chi Flora; Lingadahalli, Shreyas; Morova, Tunc; Ozturan, Dogancan; Hu, Eugene; Yu, Ivan Pak Lok; Linder, Simon; Hoogstraat, Marlous; Stelloo, Suzan; Sar, Funda; van der Poel, Henk; Altintas, Umut Berkay; Saffarzadeh, Mohammadali; Le Bihan, Stephane; McConeghy, Brian; Gokbayrak, Bengul; Feng, Felix Y; Gleave, Martin E; Bergman, Andries M; Collins, Colin; Hach, Faraz; Zwart, Wilbert; Emberly, Eldon; Lack, Nathan A.
Affiliation
  • Huang CF; Vancouver Prostate Centre, Department of Urologic Science, University of British Columbia, Vancouver, Canada.
  • Lingadahalli S; Vancouver Prostate Centre, Department of Urologic Science, University of British Columbia, Vancouver, Canada.
  • Morova T; Vancouver Prostate Centre, Department of Urologic Science, University of British Columbia, Vancouver, Canada.
  • Ozturan D; School of Medicine, Koç University, Istanbul, Turkey.
  • Hu E; Koç University Research Centre for Translational Medicine (KUTTAM), Koç University, Istanbul, Turkey.
  • Yu IPL; Department of Physics, Simon Fraser University, Burnaby, Canada.
  • Linder S; Vancouver Prostate Centre, Department of Urologic Science, University of British Columbia, Vancouver, Canada.
  • Hoogstraat M; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Stelloo S; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Sar F; Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • van der Poel H; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Altintas UB; Vancouver Prostate Centre, Department of Urologic Science, University of British Columbia, Vancouver, Canada.
  • Saffarzadeh M; Division of Urology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Le Bihan S; School of Medicine, Koç University, Istanbul, Turkey.
  • McConeghy B; Koç University Research Centre for Translational Medicine (KUTTAM), Koç University, Istanbul, Turkey.
  • Gokbayrak B; Vancouver Prostate Centre, Department of Urologic Science, University of British Columbia, Vancouver, Canada.
  • Feng FY; Vancouver Prostate Centre, Department of Urologic Science, University of British Columbia, Vancouver, Canada.
  • Gleave ME; Vancouver Prostate Centre, Department of Urologic Science, University of British Columbia, Vancouver, Canada.
  • Bergman AM; School of Medicine, Koç University, Istanbul, Turkey.
  • Collins C; Koç University Research Centre for Translational Medicine (KUTTAM), Koç University, Istanbul, Turkey.
  • Hach F; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, USA.
  • Zwart W; Vancouver Prostate Centre, Department of Urologic Science, University of British Columbia, Vancouver, Canada.
  • Emberly E; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Lack NA; Division of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Genome Biol ; 22(1): 149, 2021 05 11.
Article in En | MEDLINE | ID: mdl-33975627
BACKGROUND: Androgen receptor (AR) is critical to the initiation, growth, and progression of prostate cancer. Once activated, the AR binds to cis-regulatory enhancer elements on DNA that drive gene expression. Yet, there are 10-100× more binding sites than differentially expressed genes. It is unclear how or if these excess binding sites impact gene transcription. RESULTS: To characterize the regulatory logic of AR-mediated transcription, we generated a locus-specific map of enhancer activity by functionally testing all common clinical AR binding sites with Self-Transcribing Active Regulatory Regions sequencing (STARRseq). Only 7% of AR binding sites displayed androgen-dependent enhancer activity. Instead, the vast majority of AR binding sites were either inactive or constitutively active enhancers. These annotations strongly correlated with enhancer-associated features of both in vitro cell lines and clinical prostate cancer samples. Evaluating the effect of each enhancer class on transcription, we found that AR-regulated enhancers frequently interact with promoters and form central chromosomal loops that are required for transcription. Somatic mutations of these critical AR-regulated enhancers often impact enhancer activity. CONCLUSIONS: Using a functional map of AR enhancer activity, we demonstrated that AR-regulated enhancers act as a regulatory hub that increases interactions with other AR binding sites and gene promoters.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptors, Androgen / Enhancer Elements, Genetic Limits: Humans / Male Language: En Journal: Genome Biol Journal subject: BIOLOGIA MOLECULAR / GENETICA Year: 2021 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptors, Androgen / Enhancer Elements, Genetic Limits: Humans / Male Language: En Journal: Genome Biol Journal subject: BIOLOGIA MOLECULAR / GENETICA Year: 2021 Document type: Article Affiliation country: Country of publication: